 Connection
Elisa Birnbaum to Rectal Neoplasms
This is a "connection" page, showing publications Elisa Birnbaum has written about Rectal Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.867 |
|
|
|
-
Moyer AM, Vogel JD, Lai SH, Kim H, Chin RI, Moskalenko M, Olsen JR, Birnbaum EH, Silviera ML, Mutch MG, Chapman BC. Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy. J Gastrointest Surg. 2023 05; 27(5):980-989.
Score: 0.188
-
Lai SH, Vogel JD, Vemuru S, Messersmith W, Lieu C, McCarter MD, Birnbaum E, Chapman BC. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response. Dis Colon Rectum. 2023 07 01; 66(7):983-993.
Score: 0.186
-
Chapman BC, Lai SH, Friedrich T, Lieu CH, Moskalenko M, Olsen JR, Herter W, Birnbaum EH, McCarter MD, Vogel JD. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy. Dis Colon Rectum. 2023 04 01; 66(4):521-530.
Score: 0.174
-
Birnbaum EH, Ogunbiyi OA, Gagliardi G, Fry RD, Myerson RJ, Kodner IJ, Fleshman JW. Selection criteria for treatment of rectal cancer with combined external and endocavitary radiation. Dis Colon Rectum. 1999 Jun; 42(6):727-33; discussion 733-5.
Score: 0.145
-
Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR, Maun DC, Chang GJ, Herline A, Fichera A, Mutch MG, Wexner SD, Whiteford MH, Marks J, Birnbaum E, Margolin DA, Larson DW, Marcello PW, Posner MC, Read TE, Monson JRT, Wren SM, Pisters PWT, Nelson H. Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Ann Surg. 2019 04; 269(4):589-595.
Score: 0.144
-
Chapman BC, Goodman K, Hosokawa P, Gleisner A, Cowan ML, Birnbaum E, Vogel JD. Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB. J Surg Oncol. 2019 Mar; 119(4):518-531.
Score: 0.142
-
Roy A, Mahasittiwat P, Weiner AA, Hunt SR, Mutch MG, Birnbaum EH, Kodner IJ, Read TE, Fleshman JW, Olsen JR, Myerson RJ, Parikh PJ. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e51-e58.
Score: 0.120
-
Klos CL, Safar B, Wise PE, Hunt SR, Mutch MG, Birnbaum EH, Fleshman JW, Dharmarajan S. Impaired outcome colitis-associated rectal cancer versus sporadic cancer. J Surg Res. 2016 07; 204(1):123-9.
Score: 0.116
-
Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015 Oct 06; 314(13):1346-55.
Score: 0.113
-
Birnbaum EH, Myerson RJ, Fry RD, Kodner IJ, Fleshman JW. Chronic effects of pelvic radiation therapy on anorectal function. Dis Colon Rectum. 1994 Sep; 37(9):909-15.
Score: 0.105
-
Myerson RJ, Tan B, Hunt S, Olsen J, Birnbaum E, Fleshman J, Gao F, Hall L, Kodner I, Lockhart AC, Mutch M, Naughton M, Picus J, Rigden C, Safar B, Sorscher S, Suresh R, Wang-Gillam A, Parikh P. Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):829-36.
Score: 0.101
-
Strouch MJ, Zhou G, Fleshman JW, Birnbaum EH, Hunt SR, Mutch MG. Time to initiation of postoperative chemotherapy: an outcome measure for patients undergoing laparoscopic resection for rectal cancer. Dis Colon Rectum. 2013 Aug; 56(8):945-51.
Score: 0.097
-
Patel JA, Fleshman JW, Hunt SR, Safar B, Birnbaum EH, Lin AY, Mutch MG. Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy? Dis Colon Rectum. 2012 Mar; 55(3):249-55.
Score: 0.088
-
Dharmarajan S, Shuai D, Fajardo AD, Birnbaum EH, Hunt SR, Mutch MG, Fleshman JW, Lin AY. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer. J Gastrointest Surg. 2011 Aug; 15(8):1368-74.
Score: 0.083
-
Baik SH, Gincherman M, Mutch MG, Birnbaum EH, Fleshman JW. Laparoscopic vs open resection for patients with rectal cancer: comparison of perioperative outcomes and long-term survival. Dis Colon Rectum. 2011 Jan; 54(1):6-14.
Score: 0.081
-
Cellini C, Hunt SR, Fleshman JW, Birnbaum EH, Bierhals AJ, Mutch MG. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor? World J Surg. 2010 May; 34(5):1102-8.
Score: 0.077
-
Finan KR, Lewis JS, Winslow E, Mutch MG, Birnbaum EH, Fleshman JW. Ex vivo sentinel lymph node mapping in patients undergoing proctectomy for rectal cancer. Dis Colon Rectum. 2010 Mar; 53(3):243-50.
Score: 0.077
-
Stewart D, Yan Y, Mutch M, Kodner I, Hunt S, Lowney J, Birnbaum E, Read T, Fleshman J, Dietz D. Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy. Colorectal Dis. 2008 Nov; 10(9):879-86.
Score: 0.070
-
Ristvedt SL, Birnbaum EH, Dietz DW, Fleshman JW, Kodner IJ, Read TE. Delayed treatment for rectal cancer. Dis Colon Rectum. 2005 Sep; 48(9):1736-41.
Score: 0.056
-
Glasgow SC, Birnbaum EH, Lowney JK, Fleshman JW, Kodner IJ, Mutch DG, Lewin S, Mutch MG, Dietz DW. Retrorectal tumors: a diagnostic and therapeutic challenge. Dis Colon Rectum. 2005 Aug; 48(8):1581-7.
Score: 0.056
-
Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG, Kodner IJ. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum. 2004 Jun; 47(6):825-31.
Score: 0.051
-
Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):84-9.
Score: 0.049
-
Myerson R, Zobeiri I, Birnbaum E, Dietz D, Fleshman J, Kodner I, Picus J, Ratkin G. Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma. Semin Oncol. 2002 Dec; 29(6 Suppl 19):29-33.
Score: 0.046
-
Read TE, Myerson RJ, Fleshman JW, Fry RD, Birnbaum EH, Walz BJ, Kodner IJ. Surgeon specialty is associated with outcome in rectal cancer treatment. Dis Colon Rectum. 2002 Jul; 45(7):904-14.
Score: 0.045
-
Read TE, Ogunbiyi OA, Fleshman JW, Birnbaum EH, Fry RD, Myerson RJ, Kodner IJ. Neoadjuvant external beam radiation and proctectomy for adenocarcinoma of the rectum. Dis Colon Rectum. 2001 Dec; 44(12):1778-90.
Score: 0.043
-
Aumock A, Birnbaum EH, Fleshman JW, Fry RD, Gambacorta MA, Kodner IJ, Malyapa RS, Read TE, Walz BJ, Myerson RJ. Treatment of rectal adenocarcinoma with endocavitary and external beam radiotherapy: results for 199 patients with localized tumors. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):363-70.
Score: 0.043
-
Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, Gambacorta MA, Genovesi D, Kodner IJ, Picus J, Ratkin GA, Read TE. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. Int J Radiat Oncol Biol Phys. 2001 Aug 01; 50(5):1299-308.
Score: 0.042
-
Myerson RJ, Singh A, Birnbaum EH, Fry RD, Fleshman JW, Kodner IJ, Lockett MA, Picus J, Walz BJ, Read TE. Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2001 Jul 01; 50(3):665-74.
Score: 0.042
-
Read TE, McNevin MS, Gross EK, Whiteford HM, Lewis JL, Ratkin G, Picus J, Birnbaum EH, Fleshman JW, Kodner IJ, Myerson RJ. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis Colon Rectum. 2001 Apr; 44(4):513-22.
Score: 0.041
-
Singh AK, Myerson RJ, Birnbaum EH, Fleshman JW, Kodner IJ, Lockett MA, Read TE. Outcome of patients with rectal adenocarcinoma and localized pelvic non-nodal metastatic foci. Dis Colon Rectum. 2000 Sep; 43(9):1217-21.
Score: 0.040
-
Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000 Jun; 43(6):759-67; discussion 767-70.
Score: 0.039
-
Fleshman JW, Wexner SD, Anvari M, LaTulippe JF, Birnbaum EH, Kodner IJ, Read TE, Nogueras JJ, Weiss EG. Laparoscopic vs. open abdominoperineal resection for cancer. Dis Colon Rectum. 1999 Jul; 42(7):930-9.
Score: 0.037
-
Myerson RJ, Genovesi D, Lockett MA, Birnbaum E, Fleshman J, Fry R, Kodner I, Menteer J, Picus J, Read T, Walz B. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment. Int J Radiat Oncol Biol Phys. 1999 Feb 01; 43(3):537-43.
Score: 0.036
-
Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ. Aggressive surgical management of recurrent rectal cancer--is it worthwhile? Dis Colon Rectum. 1997 Feb; 40(2):150-5.
Score: 0.031
-
Desai GR, Myerson RJ, Higashikubo R, Birnbaum E, Fleshman J, Fry R, Kodner I, Kucik N, Lacey D, Ribeiro M. Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum. 1996 Oct; 39(10):1090-6.
Score: 0.030
-
Myerson RJ, Michalski JM, King ML, Birnbaum E, Fleshman J, Fry R, Kodner I, Lacey D, Lockett MA. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):41-50.
Score: 0.027
-
Wu JS, Birnbaum EH, Fleshman JW. Early experience with laparoscopic abdominoperineal resection. Surg Endosc. 1997 May; 11(5):449-55.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|